[Development of psychological and intellectual performance in transplanted sickle cell disease patients: a prospective study from pretransplant period to 5 years after HSCT].

PubWeight™: 0.77‹?›

🔗 View Article (PMID 23769628)

Published in Arch Pediatr on June 12, 2013

Authors

J Bockenmeyer1, E Chamboredon, F Missud, M Benkerrou, L Holvoët, G Ithier, B Lescoeur, K Yakouben, M Ouachée-Chardin, P-S Rohrlich, M Duval, A Baruchel, J-H Dalle

Author Affiliations

1: Service d'hématologie et immunologie pédiatrique, hôpital Robert-Debré, Assistance publique-Hôpitaux de Paris, 48, boulevard Sérurier, 75935 Paris cedex 19, France.

Articles citing this

Update of hematopoietic cell transplantation for sickle cell disease. Curr Opin Hematol (2015) 0.82

Articles by these authors

Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia. N Engl J Med (2000) 3.77

Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008. Leukemia (2009) 2.30

Prospective sandwich enzyme-linked immunosorbent assay for serum galactomannan: early predictive value and clinical use in invasive aspergillosis. Pediatr Infect Dis J (1996) 1.93

BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Institut Curie Breast Cancer Group. Am J Hum Genet (1997) 1.91

HLA-mismatched cord-blood transplantation in a patient with advanced leukemia. Transplantation (1992) 1.84

Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML). Leukemia (2006) 1.76

Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements. Leukemia (2003) 1.64

Acute childhood leukaemia and residence next to petrol stations and automotive repair garages: the ESCALE study (SFCE). Occup Environ Med (2009) 1.56

NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951. Leukemia (2010) 1.54

Day-care, early common infections and childhood acute leukaemia: a multicentre French case-control study. Br J Cancer (2002) 1.53

Multicenter prospective study of children with sickle cell disease: radiographic and psychometric correlation. J Child Neurol (2000) 1.52

Laparoscopic approach as primary treatment of common bile duct stones in children. J Pediatr Surg (2005) 1.51

Investigation of drug absorption from the gastrointestinal tract of man. I. Metoprolol in the stomach, duodenum and jejunum. Br J Clin Pharmacol (1985) 1.48

[Imerslund's disease. Clinical and biological aspects. Apropos of 6 cases]. Arch Pediatr (1997) 1.44

Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Société Française de Greffe de Moelle (SFGM). Bone Marrow Transplant (2000) 1.44

Incidence of childhood leukaemia and non-Hodgkin's lymphoma in France: National Registry of Childhood Leukaemia and Lymphoma, 1990-1999. Eur J Cancer Prev (2004) 1.43

Elective laparoscopic cholecystectomy. Surg Endosc (2000) 1.42

Treatment of juvenile chronic myelomonocytic leukemia by allogeneic bone marrow transplantation. Bone Marrow Transplant (1994) 1.38

Long-term outcomes after allogeneic stem cell transplantation for children with hematological malignancies. Bone Marrow Transplant (2007) 1.28

Acute childhood leukaemia and environmental exposure to potential sources of benzene and other hydrocarbons; a case-control study. Occup Environ Med (2004) 1.25

Clinical, immunological, and pathological consequences of Fas-deficient conditions. Lancet (1996) 1.23

Investigation of drug absorption from the gastrointestinal tract of man. II. Metoprolol in the jejunum and ileum. Br J Clin Pharmacol (1985) 1.22

Treatment of childhood acute myeloblastic leukemia: dose intensification improves outcome and maintenance therapy is of no benefit--multicenter studies of the French LAME (Leucémie Aiguë Myéloblastique Enfant) Cooperative Group. Leukemia (2005) 1.19

Genetic polymorphisms and childhood acute lymphoblastic leukemia: GWAS of the ESCALE study (SFCE). Leukemia (2012) 1.16

Expression of CD34 and CD7 on human T-cell acute lymphoblastic leukemia discriminates functionally heterogeneous cell populations. Leukemia (2011) 1.16

NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern. Leukemia (2013) 1.16

Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children. Bone Marrow Transplant (2001) 1.14

Germline mutations of the CBL gene define a new genetic syndrome with predisposition to juvenile myelomonocytic leukaemia. J Med Genet (2010) 1.14

Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy. J Clin Oncol (2004) 1.13

Cyclin D2 dysregulation by chromosomal translocations to TCR loci in T-cell acute lymphoblastic leukemias. Leukemia (2006) 1.12

Treatment of Chediak-Higashi syndrome by allogenic bone marrow transplantation: report of 10 cases. Blood (1995) 1.11

Investigation of drug absorption from the gastrointestinal tract of man. III. Metoprolol in the colon. Br J Clin Pharmacol (1985) 1.09

Treatment of familial hemophagocytic lymphohistiocytosis with bone marrow transplantation from HLA genetically nonidentical donors. Blood (1997) 1.07

Immune reconstitution in severe combined immunodeficiency disease after lectin-treated, T-cell-depleted haplocompatible bone marrow transplantation. Blood (1993) 1.07

Household exposure to pesticides and risk of childhood acute leukaemia. Occup Environ Med (2006) 1.06

Amplification of band q22 of chromosome 21, including AML1, in older children with acute lymphoblastic leukemia: an emerging molecular cytogenetic subgroup. Leukemia (2003) 1.05

Molecular analysis of clonality in Castleman's disease. Blood (1995) 1.04

Molecular epidemiology provides evidence of genotypic heterogeneity of multidrug-resistant Pseudomonas aeruginosa serotype O:12 outbreak isolates from a pediatric hospital. J Clin Microbiol (1996) 1.03

Colocalization of a high molecular mass phosphoprotein of the nuclear matrix (p255) with spliceosomes. J Cell Sci (1995) 1.02

Fatal diffuse capillaritis after hematopoietic stem-cell transplantation for dyskeratosis congenita despite low-intensity conditioning regimen. Bone Marrow Transplant (2005) 1.01

Defective CTLA-4 cycling pathway in Chediak-Higashi syndrome: a possible mechanism for deregulation of T lymphocyte activation. Proc Natl Acad Sci U S A (1999) 1.00

Influence of heavy chain constant regions on antigen binding and HIV-1 neutralization by a human monoclonal antibody. J Immunol (1995) 0.99

Bone marrow transplantation in major histocompatibility complex class II deficiency: a single-center study of 19 patients. Blood (1995) 0.98

Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin's disease: analysis of 280 patients from the French registry. Société Française de Greffe de Moëlle. Bone Marrow Transplant (1997) 0.98

Results of allogeneic bone marrow transplantation in patients with leukocyte adhesion deficiency. Blood (1995) 0.97

Results of an unrelated transplant search strategy using partially HLA-mismatched cord blood as an immediate alternative to HLA-matched bone marrow. Bone Marrow Transplant (2004) 0.97

Acute clinical events in 299 homozygous sickle cell patients living in France. French Study Group on Sickle Cell Disease. Eur J Haematol (2000) 0.97

The seventh international childhood acute lymphoblastic leukemia workshop report: Palermo, Italy, January 29--30, 2005. Leukemia (2005) 0.95

Chediak-Higashi syndrome associated with maternal uniparental isodisomy of chromosome 1. Eur J Hum Genet (1999) 0.95

Chronic myelomonocytic leukemia: from biology to therapy. Hematol Cell Ther (1997) 0.95

Investigation of drug absorption from the gastrointestinal tract of man. IV. Influence of food and digestive secretions on metoprolol jejunal absorption. Br J Clin Pharmacol (1985) 0.95

Age and high-dose methotrexate are associated to clinical acute encephalopathy in FRALLE 93 trial for acute lymphoblastic leukemia in children. Leukemia (2006) 0.95

Family cancer history and risk of childhood acute leukemia (France). Cancer Causes Control (2001) 0.95

Parental comprehension and satisfaction in informed consent in paediatric clinical trials: a prospective study on childhood leukaemia. Arch Dis Child (2010) 0.94

A common type of the spectrin alpha I 46-50a-kD peptide abnormality in hereditary elliptocytosis and pyropoikilocytosis is associated with a mutation distant from the proteolytic cleavage site. Evidence for the functional importance of the triple helical model of spectrin. J Clin Invest (1992) 0.94

Impact of pretransplant minimal residual disease after cord blood transplantation for childhood acute lymphoblastic leukemia in remission: an Eurocord, PDWP-EBMT analysis. Leukemia (2012) 0.94

Determination of two metoprolol metabolites in human urine by high-performance liquid chromatography. J Chromatogr (1984) 0.94

A potential graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: results from the French Bone Marrow Transplantation Society. Bone Marrow Transplant (2003) 0.93

Protein truncation test of LYST reveals heterogenous mutations in patients with Chediak-Higashi syndrome. Blood (2000) 0.93

Optimized gene transfer into human primary leukemic T cell with NOD-SCID/leukemia-initiating cell activity. Leukemia (2009) 0.93

Multicenter randomized study comparing cyclosporine-A alone and antithymocyte globulin with prednisone for treatment of severe aplastic anemia. Blood (1992) 0.93

Effect of lysine acetylsalicylate on biliary lipid secretion in dogs. Clin Sci Mol Med (1975) 0.93

Final height and gonad function after total body irradiation during childhood. Bone Marrow Transplant (2006) 0.93

Acquisition of chemoresistance following discontinuous exposures to cisplatin is associated in ovarian carcinoma cells with progressive alteration of FAK, ERK and p38 activation in response to treatment. Gynecol Oncol (2006) 0.93

Ecological distribution of Legionellaceae in the Quebec city area. Can J Microbiol (1984) 0.92

Minimal incidence of serum antibodies reactive with intact primary isolate virions in human immunodeficiency virus type 1-infected individuals. J Virol (1999) 0.92

Effect of antibody valency on interaction with cell-surface expressed HIV-1 and viral neutralization. J Immunol (1994) 0.92

Flow cytometry and IG/TCR quantitative PCR for minimal residual disease quantitation in acute lymphoblastic leukemia: a French multicenter prospective study on behalf of the FRALLE, EORTC and GRAALL. Leukemia (2012) 0.92

Phase I study of a human monoclonal antibody directed against the CD4-binding site of HIV type 1 glycoprotein 120. AIDS Res Hum Retroviruses (1998) 0.92

Granulocyte colony-stimulating factor in induction treatment of children with non-Hodgkin's lymphoma: a randomized study of the French Society of Pediatric Oncology. J Clin Oncol (2002) 0.91

Critical study of prognostic factors in childhood acute lymphoblastic leukaemia: differences in outcome are poorly explained by the most significant prognostic variables. Fralle group. French Acute Lymphoblastic Leukaemia study group. Br J Haematol (1998) 0.91

Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukemia, treated in the Société Française d'Oncologie Pédiatrique LMB89 protocol. Ann Oncol (2002) 0.91

Pertrochanteric fractures treated with the Gamma nail: technique and report of early results. Orthopedics (1991) 0.91

Bone marrow transplantation (BMT) in Europe for primary immunodeficiencies other than severe combined immunodeficiency: a report from the European Group for BMT and the European Group for Immunodeficiency. Blood (1994) 0.91

Effect of age and single versus multiple dose pharmacokinetics of letrozole (Femara) in breast cancer patients. Biopharm Drug Dispos (2001) 0.90

Cytotoxic T cell response against the chimeric ETV6-AML1 protein in childhood acute lymphoblastic leukemia. J Clin Invest (1998) 0.90

Engraftment of unrelated cord blood after reduced-intensity conditioning regimen in children with refractory neuroblastoma: a feasibility trial. Bone Marrow Transplant (2010) 0.89

[Fanconi anemia in 2012: diagnosis, pediatric follow-up and treatment]. Arch Pediatr (2012) 0.89

Peripheral T-cell expansion and low infection rate after reduced-intensity conditioning and allogeneic blood stem cell transplantation. Bone Marrow Transplant (2005) 0.89

Thiamine responsive anemia: report of a new case associated with a thiamine pyrophosphokinase deficiency. Nouv Rev Fr Hematol (1991) 0.88

Reconstitution of maturating and regulatory lymphocyte subsets after cord blood and BMT in children. Bone Marrow Transplant (2012) 0.88

Development, application and comparison of an enzyme immunoassay and a high-performance liquid chromatography method for the determination of the aromatase inhibitor CGS 20,267 in biological fluids. J Pharm Sci (1994) 0.88

Pharmacokinetics of liposomal daunorubicin (DaunoXome) during a phase I-II study in children with relapsed acute lymphoblastic leukaemia. Cancer Chemother Pharmacol (2001) 0.87

Prospective monitoring and quantitation of residual blasts in childhood acute lymphoblastic leukemia by polymerase chain reaction study of delta and gamma T-cell receptor genes. Blood (1994) 0.87

Evaluation of minimal residual disease using reverse-transcription polymerase chain reaction in t(8;21) acute myeloid leukemia: a multicenter study of 51 patients. J Clin Oncol (2000) 0.86

Brief report: correction of X-linked hyper-IgM syndrome by allogeneic bone marrow transplantation. N Engl J Med (1995) 0.86

Failure of granulocyte colony-stimulating factor in alloimmune neonatal neutropenia. J Pediatr (1995) 0.86

Pediatric laparoscopic splenectomy: benefits of the anterior approach. Surg Endosc (2003) 0.86

No prognostic effect of additional chromosomal abnormalities in children with acute lymphoblastic leukemia and 11q23 abnormalities. Leukemia (2005) 0.86

High BRE expression in pediatric MLL-rearranged AML is associated with favorable outcome. Leukemia (2010) 0.86

Novel inhibitors of nucleoside triphosphate diphosphohydrolases: chemical synthesis and biochemical and pharmacological characterizations. J Med Chem (2000) 0.86

Prognostic study of continuous variables (white blood cell count, peripheral blast cell count, haemoglobin level, platelet count and age) in childhood acute lymphoblastic leukaemia. Analysis Of a population of 1545 children treated by the French Acute Lymphoblastic Leukaemia Group (FRALLE). Br J Cancer (2000) 0.86

[Neonatal syphilis despite erythromycin treatment of the mother]. Presse Med (1984) 0.85

Influence of dehydrocholate and taurocholate on bromsulphthalein uptake, storage, and excretion in the dog. Gut (1975) 0.85

[Intravenously administered gamma-globulins in reactive hemaphagocytic syndrome. Multicenter study to assess their importance, by the immunoglobulins group of experts of CEDIT of the AP-HP]. Ann Med Interne (Paris) (2000) 0.85

NMR-like control of a quantum bit superconducting circuit. Phys Rev Lett (2004) 0.85

Cloning and expression of the pea gene encoding SBP65, a seed-specific biotinylated protein. Plant Mol Biol (1997) 0.85